http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005028016-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7733de6f1f3f113100ed2fd12c4a3f68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d841291474c9da3a670c85eeafae261
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M37-0069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M31-00
filingDate 2004-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45468600a07dbbfaab4d65ce017ebad9
publicationDate 2005-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005028016-A1
titleOfInvention Chemoablation of tissue using biodegradable, solid salt dosage forms
abstract Novel methods for the chemical ablation of tissue (e.g. prostatic tissue) are described. These methods include the steps of : (a) providing one or more solid salt dosage form comprising 50-100% w/w salt; and (b) inserting one or more of such solid salt dosage forms into the tissue. The solid salt dosage form is optionally inserted into the tissue under real-time ultrasonic observation. An advantage of the present invention is its ability to eliminate toxic byproducts. For example, where NaCl-based solid salt dosage forms are used to effect localized chemical ablation, the concentration is ultimately reduced to the level of normal saline (i.e., about 0.9%) upon absorption by the body of the subject being treated.
priorityDate 2003-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2123818-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03043606-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4873
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406004
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3676
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128727325
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453569306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727

Total number of triples: 27.